Skip Navigation

watchlive

Pre-Markets
U.S. Markets
Currencies
Cryptocurrency
Futures & Commodities
Bonds
Funds & ETFs

Economy
Finance
Health & Science
Media
Real Estate
Energy
Climate
Transportation
Industrials
Retail
Wealth
Sports
Life
Small Business

Personal Finance
Fintech
Financial Advisors
Options Action
ETF Street
Buffett Archive
Earnings
Trader Talk

Cybersecurity
Enterprise
Internet
Media
Mobile
Social Media
CNBC Disruptor 50
Tech Guide

White House
Policy
Defense
Congress
Equity and Opportunity

Live TV
Live Audio
Business Day Shows
Entertainment Shows
Full Episodes
Latest Video
Top Video
CEO Interviews
CNBC Documentaries
CNBC Podcasts
CNBC World
Digital Originals
Live TV Schedule

Trust Portfolio
Analysis
Trade Alerts
Meeting Videos
Homestretch
Jim's Columns
Education
Subscribe
Sign In

Pro News
Pro Live
Full Episodes
Stock Screener
Market Forecast
Options Investing
Chart Investing
Subscribe
Sign In

Make It

USA
INTL

watchlive

Get Jim Cramer’s rapid-fire takeaways on 5 stocks in the news Thursday

Published Thu, Feb 1 202411:02 AM EST

Matthew J. Belvedere @Matt_Belvedere

Merck — Jim Cramer described Merck's results as a "monster quarter," pointing out cancer drug Keytruda, which saw sales up double digits on a percentage basis. Merck's guidance for 2024 was in line with expectations. The CNBC Investing Club portfolio owns a few health- and drug-related stocks, including the outperforming Eli Lilly . Align Technology — Shares of the Invisalign company were up after reporting a better-than-expected quarter. Jim calls it a "unique situation." It had been a "miss, miss, miss," but now that Covid is over people are doing things they put off. Royal Caribbean — The cruise line delivered a stronger-than-expected profit outlook for 2024, sending the stock higher initially before reversing modestly to the downside. Jim said he's "surprised this isn't up." Bookings were on pace for record rates and volume. Etsy — The marketplace for handmade goods announced Marc Steinberg, a partner at activist investment group Elliot Management, as a new board member. Steinberg "helped turnaround Pinterest," Jim said, adding that he sees Etsy at around $73 per share as a buy. Peloton — The stock was getting slammed as a slight sales beat was overshadowed by a wider loss than expected and soft guidance. Jim said, "It's a show me story and they have not shown me yet." He said he thought new management would have been able to turn things around faster. "Not my cup of tea," he concluded.

Subscribe to CNBC PRO
Subscribe to Investing Club
Licensing & Reprints
CNBC Councils
Select Personal Finance
CNBC on Peacock
Join the CNBC Panel
Supply Chain Values
Select Shopping
Closed Captioning
Digital Products
News Releases
Internships
Corrections
About CNBC
Ad Choices
Site Map
Podcasts
Careers
Help
Contact

News Tips
Got a confidential news tip? We want to hear from you.
Get In Touch
CNBC Newsletters
Sign up for free newsletters and get more CNBC delivered to your inbox
Sign Up Now
Get this delivered to your inbox, and more info about our products and services.
Advertise With Us
Please Contact Us

Privacy Policy
CA Notice
Terms of Service

© 2024 CNBC LLC. All Rights Reserved. A Division of NBCUniversal

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided by